Paid Clinical Trials Pasadena
Discover 3,371 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Sponsor:
Pfizer
Location:
Code:
NCT06760637
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07220060
letrozole
abemaciclib
palbociclib
ribociclib
Breast Cancer DetectionEarlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Sponsor:
SonoCine, Inc.
Location:
Code:
NCT00649337
Conditions
Breast Neoplasms
Ultrasonography
Eligibility Criteria
Sex: Female
Age: 35 - 70+
Healthy Volunteers: Accepted
Interventions
Comparison of Automated Whole Breast Ultrasound Screening with Blinded Screening Mammography
BHV-7000A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Sponsor:
Biohaven Therapeutics Ltd.
Location:
Code:
NCT06425159
Conditions
Generalized Epilepsy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BHV-7000
Placebo
FisetinFisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Sponsor:
Jonsson Comprehensive Cancer Center
Location:
Code:
NCT05595499
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Eligibility Criteria
Sex: Female
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Fisetin
Placebo Administration
Quality-of-Life Assessment
Questionnaire Administration
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BarzolvolimabA Study of Barzolvolimab in Patients With Atopic Dermatitis
Sponsor:
Celldex Therapeutics
Location:
Code:
NCT06727552
Conditions
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Barzolvolimab
Matching placebo
Observational StudyFilipino Family Health Initiative 1.0
Sponsor:
Kaiser Permanente
Location:
Code:
NCT06569303
Conditions
Depression
Anxiety
Parenting
Eligibility Criteria
Sex: All
Age: 8+
Healthy Volunteers: Accepted
Interventions
Incredible Years® School Age Basic Parent Training Program
American Academy of Pediatrics, Bright Futures Handouts
KHK4951Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Sponsor:
Kyowa Kirin Co., Ltd.
Location:
Code:
NCT06116890
Conditions
Neovascular Age-Related Macular Degeneration (nAMD)
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
KHK4951
Aflibercept Injection
BI 764524A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06321302
Conditions
Diabetic Retinopathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BI 764524
Sham comparator to BI 764524
Aflibercept (Eylea®) - US only
BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Sponsor:
Atea Pharmaceuticals, Inc.
Location:
Code:
NCT06868264
Conditions
HEPATITIS C VIRUS CHRONIC INFECTION
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bemnifosbuvir-Ruzasvir (BEM/RZR)
Sofosbuvir-Velpatasvir (SOF/VEL)